OpenURL Connection Search

Select item for more details and to access through your institution.

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
Published in:
International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 10902, doi. 10.3390/ijms222010902
By:
- van der Sijde, Fleur;
- Homs, Marjolein Y. V.;
- van Bekkum, Marlies L.;
- van den Bosch, Thierry P. P.;
- Bosscha, Koop;
- Besselink, Marc G.;
- Bonsing, Bert A.;
- de Groot, Jan Willem B.;
- Karsten, Thomas M.;
- Groot Koerkamp, Bas;
- Haberkorn, Brigitte C. M.;
- Luelmo, Saskia A. C.;
- Mekenkamp, Leonie J. M.;
- Mustafa, Dana A. M.;
- Wilmink, Johanna W.;
- van Eijck, Casper H. J.;
- Vietsch, Eveline E.
Publication type:
Article
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.898498
By:
- van der Sijde, Fleur;
- Dik, Willem A.;
- Mustafa, Dana A. M.;
- Vietsch, Eveline E.;
- Besselink, Marc G.;
- Debets, Reno;
- Koerkamp, Bas Groot;
- Haberkorn, Brigitte C. M.;
- Homs, Marjolein Y. V.;
- Janssen, Quisette P.;
- Luelmo, Saskia A. C.;
- Mekenkamp, Leonie J. M.;
- Oostvogels, Astrid A. M.;
- Smits-te Nijenhuis, Marja A. W.;
- Wilmink, Johanna W.;
- van Eijck, Casper H. J.
Publication type:
Article
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211033704
By:
- van der Sijde, Fleur;
- Azmani, Zakia;
- Besselink, Marc G.;
- Bonsing, Bert A.;
- de Groot, Jan Willem B.;
- Groot Koerkamp, Bas;
- Haberkorn, Brigitte C. M.;
- Homs, Marjolein Y. V.;
- van IJcken, Wilfred F. J.;
- Janssen, Quisette P.;
- Lolkema, Martijn P.;
- Luelmo, Saskia A. C.;
- Mekenkamp, Leonie J. M.;
- Mustafa, Dana A. M.;
- van Schaik, Ron H. N.;
- Wilmink, Johanna W.;
- Vietsch, Eveline E.;
- van Eijck, Casper H. J.
Publication type:
Article
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211033704
By:
- van der Sijde, Fleur;
- Azmani, Zakia;
- Besselink, Marc G.;
- Bonsing, Bert A.;
- de Groot, Jan Willem B.;
- Groot Koerkamp, Bas;
- Haberkorn, Brigitte C. M.;
- Homs, Marjolein Y. V.;
- van IJcken, Wilfred F. J.;
- Janssen, Quisette P.;
- Lolkema, Martijn P.;
- Luelmo, Saskia A. C.;
- Mekenkamp, Leonie J. M.;
- Mustafa, Dana A. M.;
- van Schaik, Ron H. N.;
- Wilmink, Johanna W.;
- Vietsch, Eveline E.;
- van Eijck, Casper H. J.
Publication type:
Article
Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent.
Published in:
PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0086833
By:
- Mekenkamp, Leonie J. M.;
- Haan, Josien C.;
- Israeli, Daniëlle;
- van Essen, Hendrik F. B.;
- Dijkstra, Jeroen R.;
- van Cleef, Patricia;
- Punt, Cornelis J. A.;
- Meijer, Gerrit A.;
- Nagtegaal, Iris D.;
- Ylstra, Bauke
Publication type:
Article
Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer.
Published in:
Cancers, 2022, v. 14, n. 4, p. 1001, doi. 10.3390/cancers14041001
By:
- Smit, Karel C.;
- Derksen, Jeroen W. G.;
- Beets, Geerard L. O.;
- Belt, Eric J. Th.;
- Berbée, Maaike;
- Coene, Peter Paul L. O.;
- van Cruijsen, Hester;
- Davidis, Marjan A.;
- Dekker, Jan Willem T.;
- van Dodewaard-de Jong, Joyce M.;
- Haringhuizen, Annebeth W.;
- Helgason, Helgi H.;
- Hendriks, Mathijs P.;
- Hoekstra, Ronald;
- de Hingh, Ignace H. J. T.;
- IJzermans, Jan N. M.;
- Janssen, Johan J. B.;
- Konsten, Joop L. M.;
- Los, Maartje;
- Mekenkamp, Leonie J. M.
Publication type:
Article
Genomic landscape of metastatic colorectal cancer.
Published in:
Nature Communications, 2014, v. 5, n. 11, p. 5457, doi. 10.1038/ncomms6457
By:
- Haan, Josien C.;
- Labots, Mariette;
- Rausch, Christian;
- Koopman, Miriam;
- Tol, Jolien;
- Mekenkamp, Leonie J. M.;
- van de Wiel, Mark A.;
- Israeli, Danielle;
- van Essen, Hendrik F.;
- van Grieken, Nicole C. T.;
- Voorham, Quirinus J. M.;
- Bosch, Linda J. W.;
- Qu, Xueping;
- Kabbarah, Omar;
- Verheul, Henk M. W.;
- Nagtegaal, Iris D.;
- Punt, Cornelis J. A.;
- Ylstra, Bauke;
- Meijer, Gerrit A.
Publication type:
Article

Found: 7

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.

Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent.

Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer.

Genomic landscape of metastatic colorectal cancer.